NO20081253L - Klebepreparat inneholdende bisopropol - Google Patents
Klebepreparat inneholdende bisopropolInfo
- Publication number
- NO20081253L NO20081253L NO20081253A NO20081253A NO20081253L NO 20081253 L NO20081253 L NO 20081253L NO 20081253 A NO20081253 A NO 20081253A NO 20081253 A NO20081253 A NO 20081253A NO 20081253 L NO20081253 L NO 20081253L
- Authority
- NO
- Norway
- Prior art keywords
- bisoprolol
- adhesive
- adhesive composition
- skin surface
- skin
- Prior art date
Links
- 239000000853 adhesive Substances 0.000 title abstract 7
- 230000001070 adhesive effect Effects 0.000 title abstract 7
- VHYCDWMUTMEGQY-UHFFFAOYSA-N bisoprolol Chemical compound CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1 VHYCDWMUTMEGQY-UHFFFAOYSA-N 0.000 abstract 5
- 229960002781 bisoprolol Drugs 0.000 abstract 5
- 229920002367 Polyisobutene Polymers 0.000 abstract 2
- 206010040880 Skin irritation Diseases 0.000 abstract 1
- 239000012790 adhesive layer Substances 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 239000010410 layer Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000036556 skin irritation Effects 0.000 abstract 1
- 231100000475 skin irritation Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Det tilveiebringes et adhesivt preparat som har en lav irritasjon overfor hudoverflaten, har fremragende stabilitet for bisoprolol i preparatet og videre er i stand til å kontinuerlig administrere en farmakologisk effektiv mengde av bisoprolol til den levende kroppen. Det adhesive prepratet har en bærer (1) og et klebrig sjikt (2) som er lagdelt på en overflate av bæreren (1). Det klebrige sjikt (2) er kjennetegnet ved å inneholde bisoprolol, polyisobutylen, en klebriggjører og en organisk flytende komponent som er kompatibel med polyisobutylen og klebriggjøreren. På denne måten kan det adhesive preparat som har god hudadhesjon, lav hudirritasjon og redusert smerte eller adhesjonsmiddelrest ved tidspunktet for fjerning fra hudoverflaten tilveiebringes. Videre tilveiebringes det adhesive preparat hvori stabiliteten av bisoprolol i det adhesive preparat er fremragende og den farmakologisk effektive mengde av bisoprolol kan administreres kontinuerlig til den levende kroppen gjennom hudoverflaten.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005262559 | 2005-09-09 | ||
JP2006235270A JP5058531B2 (ja) | 2005-09-09 | 2006-08-31 | ビソプロロール含有貼付製剤 |
PCT/JP2006/317764 WO2007029781A1 (ja) | 2005-09-09 | 2006-09-07 | ビソプロロール含有貼付製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081253L true NO20081253L (no) | 2008-06-09 |
Family
ID=37835896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081253A NO20081253L (no) | 2005-09-09 | 2008-03-10 | Klebepreparat inneholdende bisopropol |
Country Status (15)
Country | Link |
---|---|
US (1) | US8808731B2 (no) |
EP (2) | EP2359823A1 (no) |
JP (1) | JP5058531B2 (no) |
KR (1) | KR101246400B1 (no) |
AR (1) | AR055412A1 (no) |
AU (1) | AU2006288260B2 (no) |
BR (1) | BRPI0615762A2 (no) |
CA (1) | CA2621867C (no) |
DK (1) | DK1932523T3 (no) |
IL (1) | IL189991A (no) |
NO (1) | NO20081253L (no) |
NZ (1) | NZ566494A (no) |
RU (1) | RU2396951C2 (no) |
TW (1) | TWI426930B (no) |
WO (1) | WO2007029781A1 (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5058531B2 (ja) | 2005-09-09 | 2012-10-24 | 日東電工株式会社 | ビソプロロール含有貼付製剤 |
JP5015562B2 (ja) * | 2005-12-13 | 2012-08-29 | 日東電工株式会社 | 貼付製剤 |
JP4945228B2 (ja) * | 2005-12-13 | 2012-06-06 | 日東電工株式会社 | ビソプロロール含有貼付製剤 |
AU2008221861B2 (en) * | 2007-03-08 | 2013-03-21 | Nitto Denko Corporation | Device for the transdermal administration of bisoprolol |
WO2009026133A2 (en) * | 2007-08-17 | 2009-02-26 | Alza Corporation | Transdermal bisoprolol delivery system |
KR20100134058A (ko) | 2008-03-25 | 2010-12-22 | 데이고꾸세이약꾸가부시끼가이샤 | β-차단제의 안정화 조성물 및 이를 포함한 경피 흡수 제제 |
EP2286814B1 (en) * | 2008-05-15 | 2013-10-16 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal preparation containing palonosetron |
US20100092544A1 (en) * | 2008-10-14 | 2010-04-15 | Katsuhiro Okada | Adhesive composition for patch and use thereof |
US8702664B2 (en) | 2009-02-18 | 2014-04-22 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal preparation |
KR101725832B1 (ko) | 2009-05-01 | 2017-04-11 | 히사미쓰 세이야꾸 가부시키가이샤 | 경피 흡수형 제제 |
JP5776079B2 (ja) * | 2010-02-26 | 2015-09-09 | 日東電工株式会社 | ビソプロロール含有貼付製剤 |
JP6528154B2 (ja) * | 2013-09-06 | 2019-06-12 | 日東電工株式会社 | ビソプロロール含有貼付製剤 |
JP6318355B2 (ja) * | 2013-09-06 | 2018-05-09 | 日東電工株式会社 | ビソプロロール含有貼付製剤 |
JP2015051947A (ja) * | 2013-09-06 | 2015-03-19 | 日東電工株式会社 | ビソプロロール含有貼付製剤およびその包装体 |
JP6318356B2 (ja) * | 2013-09-06 | 2018-05-09 | 日東電工株式会社 | ビソプロロール含有貼付製剤およびその包装体 |
JP6457486B2 (ja) * | 2014-03-06 | 2019-01-23 | 帝國製薬株式会社 | 貼付製剤 |
WO2017031074A1 (en) * | 2015-08-17 | 2017-02-23 | 3M Innovative Properties Company | Nanoclay filled barrier adhesive compositons |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656286A (en) | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
JP2512565B2 (ja) * | 1989-10-13 | 1996-07-03 | 積水化学工業株式会社 | 貼付剤 |
US5508038A (en) | 1990-04-16 | 1996-04-16 | Alza Corporation | Polyisobutylene adhesives for transdermal devices |
US5149719A (en) | 1990-04-27 | 1992-09-22 | Minnesota Mining And Manufacturing Company | Composition for transdermal penetration of medicaments |
JPH0813956B2 (ja) | 1990-06-22 | 1996-02-14 | 積水化学工業株式会社 | 表面保護フィルムの製造方法 |
JP3355671B2 (ja) | 1992-11-09 | 2002-12-09 | 旭化成株式会社 | 粘接着剤用組成物 |
JPH07330591A (ja) | 1994-06-06 | 1995-12-19 | Kanegafuchi Chem Ind Co Ltd | 経皮吸収製剤 |
DE19512181C2 (de) | 1995-03-31 | 2003-11-06 | Hexal Pharma Gmbh | Transdermales System mit Ramipril und/oder Trandolapril als ACE-Hemmer |
IL122484A0 (en) | 1995-06-07 | 1998-06-15 | Noven Pharma | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
JPH10152434A (ja) * | 1996-09-26 | 1998-06-09 | Nitto Denko Corp | 経皮吸収型製剤 |
JP4119502B2 (ja) | 1997-07-08 | 2008-07-16 | 埼玉第一製薬株式会社 | 新規な経皮吸収促進剤を含有する外用剤組成物 |
JP3930984B2 (ja) * | 1997-12-12 | 2007-06-13 | 日東電工株式会社 | 経皮吸収型製剤 |
US20040142024A1 (en) | 1999-07-27 | 2004-07-22 | Hisamitsu Pharmaceutical Co., Inc. | Patch formulation for external use |
DE60033426T2 (de) * | 1999-12-15 | 2007-10-31 | Hisamitsu Pharmaceutical Co., Inc., Tosu | Adhäsive zubereitungen |
FR2807323A1 (fr) | 2000-04-10 | 2001-10-12 | Oreal | Composition, notamment cosmetique, renfermant un steroide et un 2-alkyl alcanol ou un ester |
DE10033853A1 (de) | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
JP2002038114A (ja) | 2000-07-26 | 2002-02-06 | Aicello Chemical Co Ltd | 粘着付与マスターバッチ及びこれを用いた粘着フィルム |
JP4358978B2 (ja) | 2000-09-05 | 2009-11-04 | 日東電工株式会社 | 経皮吸収製剤 |
JP2002187836A (ja) * | 2000-12-21 | 2002-07-05 | Oishi Koseido:Kk | 貼付剤 |
JP4478757B2 (ja) * | 2002-04-19 | 2010-06-09 | 日東電工株式会社 | ビソプロロール含有貼付剤 |
JP2004244585A (ja) | 2003-02-17 | 2004-09-02 | Nippon Shokubai Co Ltd | 粘着剤組成物および粘着製品 |
EP1652508B1 (en) * | 2003-07-31 | 2013-12-04 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
WO2005072716A1 (ja) * | 2004-01-30 | 2005-08-11 | Hisamitsu Pharmaceutical Co., Inc. | 貼付剤入り包装袋 |
US7168810B2 (en) | 2004-04-23 | 2007-01-30 | Infocus Corporation | Method and apparatus for arranging light emitting devices in projection systems |
JP4745747B2 (ja) | 2004-08-12 | 2011-08-10 | 日東電工株式会社 | フェンタニル含有貼付製剤 |
WO2006044206A2 (en) | 2004-10-08 | 2006-04-27 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
US20090012181A1 (en) | 2005-01-31 | 2009-01-08 | Satoshi Amano | Patch |
JP4782438B2 (ja) | 2005-02-17 | 2011-09-28 | 日東電工株式会社 | 貼付製剤 |
JP5058531B2 (ja) | 2005-09-09 | 2012-10-24 | 日東電工株式会社 | ビソプロロール含有貼付製剤 |
JP5015562B2 (ja) | 2005-12-13 | 2012-08-29 | 日東電工株式会社 | 貼付製剤 |
JP4945228B2 (ja) | 2005-12-13 | 2012-06-06 | 日東電工株式会社 | ビソプロロール含有貼付製剤 |
AU2008221861B2 (en) | 2007-03-08 | 2013-03-21 | Nitto Denko Corporation | Device for the transdermal administration of bisoprolol |
-
2006
- 2006-08-31 JP JP2006235270A patent/JP5058531B2/ja active Active
- 2006-09-06 AR ARP060103868A patent/AR055412A1/es not_active Application Discontinuation
- 2006-09-07 EP EP11003489A patent/EP2359823A1/en not_active Withdrawn
- 2006-09-07 DK DK06783221.2T patent/DK1932523T3/da active
- 2006-09-07 US US12/066,095 patent/US8808731B2/en not_active Expired - Fee Related
- 2006-09-07 RU RU2008113846/15A patent/RU2396951C2/ru not_active IP Right Cessation
- 2006-09-07 EP EP06783221A patent/EP1932523B1/en not_active Not-in-force
- 2006-09-07 CA CA2621867A patent/CA2621867C/en not_active Expired - Fee Related
- 2006-09-07 NZ NZ566494A patent/NZ566494A/en not_active IP Right Cessation
- 2006-09-07 KR KR1020087005702A patent/KR101246400B1/ko not_active IP Right Cessation
- 2006-09-07 BR BRPI0615762-9A patent/BRPI0615762A2/pt not_active IP Right Cessation
- 2006-09-07 AU AU2006288260A patent/AU2006288260B2/en not_active Ceased
- 2006-09-07 WO PCT/JP2006/317764 patent/WO2007029781A1/ja active Application Filing
- 2006-09-08 TW TW095133239A patent/TWI426930B/zh not_active IP Right Cessation
-
2008
- 2008-03-06 IL IL189991A patent/IL189991A/en not_active IP Right Cessation
- 2008-03-10 NO NO20081253A patent/NO20081253L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200800144A (en) | 2008-01-01 |
CA2621867C (en) | 2012-12-18 |
EP1932523A4 (en) | 2008-11-26 |
AU2006288260B2 (en) | 2011-05-26 |
WO2007029781A1 (ja) | 2007-03-15 |
EP1932523B1 (en) | 2011-07-27 |
IL189991A0 (en) | 2008-08-07 |
AU2006288260A1 (en) | 2007-03-15 |
NZ566494A (en) | 2010-10-29 |
BRPI0615762A2 (pt) | 2011-05-24 |
JP5058531B2 (ja) | 2012-10-24 |
EP1932523A1 (en) | 2008-06-18 |
AR055412A1 (es) | 2007-08-22 |
RU2008113846A (ru) | 2009-10-20 |
DK1932523T3 (da) | 2011-11-14 |
RU2396951C2 (ru) | 2010-08-20 |
US20090291126A1 (en) | 2009-11-26 |
IL189991A (en) | 2014-07-31 |
CA2621867A1 (en) | 2007-03-15 |
US8808731B2 (en) | 2014-08-19 |
JP2007099759A (ja) | 2007-04-19 |
EP2359823A1 (en) | 2011-08-24 |
KR20080041692A (ko) | 2008-05-13 |
TWI426930B (zh) | 2014-02-21 |
KR101246400B1 (ko) | 2013-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081253L (no) | Klebepreparat inneholdende bisopropol | |
WO2006055752A3 (en) | INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHODS OF USING THE SAME | |
WO2006002361A3 (en) | 2-methylpropanamides and their use as pharmaceuticals | |
WO2007084314A3 (en) | MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
WO2008108958A3 (en) | Benzimidazole derivatives and methods of use thereof | |
WO2007103719A3 (en) | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
WO2008137758A3 (en) | Amino acid lipids and uses thereof | |
TW200621763A (en) | Lactam compounds and their use as pharmaceuticals | |
WO2007061661A3 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
ECSP067114A (es) | Piperidinas n-sustituidas y su uso como farmacéuticos | |
CL2009000967A1 (es) | Compuesto 4-ciclobutil-n-((2s,5r)-5-hidroxi-2-adamantil)-2-morfolin-4-ilpiridin-5-carboxamida, inhibidor de la enzima 11betahsd1; composicion farmaceutica que lo comprende; y su uso en un procedimiento de tratamiento profilactico o terapeutico de un animal de sangre caliente. | |
CL2007003614A1 (es) | Compuestos derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona; composicion farmaceutica que comprende a dicho compuesto; procedimiento de preparacion; y uso del compuesto en el tratamiento de trastornos del metabolismo, como diabetes mellitus, dis | |
WO2007067504A3 (en) | Lactam compounds and methods of using the same | |
WO2007137066A3 (en) | HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME | |
WO2005116002A3 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
WO2008108957A3 (en) | Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain | |
WO2009010416A3 (en) | Inhibitors of 11b-hydroxysteroid dehydrogenase | |
NO20100301L (no) | Forbedrete brimonidinsammensetninger for behandling av erytem | |
SG151329A1 (en) | Amido compounds and their use as pharmaceuticals | |
SG163518A1 (en) | Amido compounds and their use as pharmaceuticals | |
EA201101187A1 (ru) | Антидиабетические лекарственные средства, содержащие ингибитор dpp-4 (линаглиптин) необязательно в комбинации с другими антидиабетическими средствами | |
WO2007062413A3 (en) | Use of parp-1 inhibitors | |
ECSP077309A (es) | Compuestos amido y sus usos como farmaceuticos | |
WO2008108286A1 (ja) | 経皮吸収医薬組成物、医薬組成物貯蔵ユニットおよびこれを利用する経皮吸収製剤 | |
WO2005075471A3 (en) | Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |